GB715362A - Improvements in or relating to antimicrobial agent - Google Patents
Improvements in or relating to antimicrobial agentInfo
- Publication number
- GB715362A GB715362A GB6828/52A GB682852A GB715362A GB 715362 A GB715362 A GB 715362A GB 6828/52 A GB6828/52 A GB 6828/52A GB 682852 A GB682852 A GB 682852A GB 715362 A GB715362 A GB 715362A
- Authority
- GB
- United Kingdom
- Prior art keywords
- antibiotic
- per cent
- methanol
- aqueous
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
- A01N63/28—Streptomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
An antibiotic P.A.94 is produced by cultivating a strain of Streptomyces lavendulae, No. 8197-20, which is described, in an aqueous nutrient-containing solution under submerged aerobic conditions at a temperature of 25-30 DEG C. for 2 to 4 days and then recovering the antibiotic from the fermentation broth. Specified nutrients are carbohydrates such as sugars, starch and glycerol; organic nitrogen such as soyabean meal, cottonseed meal, alfalfa meal, corn steep liquor, hydrolyzates of casein and other proteins; growth substances such as distillers' solubles, yeast extract and Vitamin B concentrates; mineral salts such as sodium chloride, potassium phosphate, sodium nitrate and calcium carbonate. After the removal of the mycelium by filtration and, if desired, a preliminary treatment with activated carbon at an acid, e.g. pH 2.0, or alkaline, e.g. pH 10.0, pH the antibiotic is isolated from the culture liquid by (a) adsorption on acidic cationic exchange resins, preferably at a pH 3.0-7.0; or (b) solvent extraction by water-immiscible alcohols, e.g. butanol and benzyl alcohol after the addition to the culture liquid of a strong organic acid such as p-toluenesulphonic acid. The resins used in the adsorption step are phenol formaldehyde resins containing sulphonic acid groups introduced by adding a sulphite during formation of the resin, e.g. Amberlite IR 120 (Registered Trade Mark); or they are sulphonated hydrocarbon polymers or polymers prepared from sulphonated phenols and formaldehyde. The antibiotic is eluted from the resin by means of dilute aqueous alkali, e.g. 0.5-3 per cent aqueous ammonia; sodium hydroxide, potassium hydroxide and strong organic bases. The antibiotic recovered from the eluate may be further purified by dissolving in water or aqueous methanol and passing down a column of a basic anion-exchange resin, alumina, silica gel or other metallic oxide. As a further purification step (a) acetone may be added to a methanol solution to precipitate impurities; (b) antibiotic may be precipitated by the addition of ethanol to aqueous solution; and (c) a carbon treatment may be given at any stage. The antibiotic P.A.94 is an amphoteric substance effective in inhibiting the growth of mycobacteria. It is soluble in water and methanol. It contains C, H, O, N in the proportions C = 34.8 per cent, H = 5.8 per cent, N = 26.9 per cent and 0 = 32.5 per cent. [a ]D25 = 640 (methanol). It exhibits a characteristic infrared absorption spectrum.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US715362XA | 1951-03-17 | 1951-03-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB715362A true GB715362A (en) | 1954-09-15 |
Family
ID=22101951
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB6828/52A Expired GB715362A (en) | 1951-03-17 | 1952-03-17 | Improvements in or relating to antimicrobial agent |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB715362A (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2772281A (en) * | 1954-12-23 | 1956-11-27 | Merck & Co Inc | Synthesis of 4-amino-3-isoxazolidone and its derivatives |
US2789983A (en) * | 1954-08-03 | 1957-04-23 | Commercial Solvents Corp | Recovery of cycloserine |
US2794022A (en) * | 1955-03-25 | 1957-05-28 | Commerical Solvents Corp | Production of cycloserine |
US2815348A (en) * | 1955-03-21 | 1957-12-03 | Commercial Solvents Corp | Process of producing acetyl cycloserine |
US2840565A (en) * | 1954-12-23 | 1958-06-24 | Merck & Co Inc | Optical isomers of 4-amino-3-isoxazolidone |
US2845433A (en) * | 1955-02-04 | 1958-07-29 | Merck & Co Inc | Extraction of 4-amino-3-isoxazolidone |
US2845432A (en) * | 1954-12-23 | 1958-07-29 | Merck & Co Inc | Benzamido and acetamido 4-amino-3-isoxazolidones and alkylated derivatives |
US2885433A (en) * | 1954-08-19 | 1959-05-05 | Lab Francais Chimiotherapie | O-carbamyl-d-serine |
US3010642A (en) * | 1955-02-16 | 1961-11-28 | Rheinische Maschinen Und App G | Radial flow supersonic compressor |
US5221625A (en) * | 1992-01-10 | 1993-06-22 | Merck & Co., Inc. | Cyclcic FR-900520 microbial biotransformation agent |
US5268281A (en) * | 1992-09-28 | 1993-12-07 | Merck & Co., Inc. | Cyclic FR-900520 microbial biotransformation agent |
US5268282A (en) * | 1992-09-28 | 1993-12-07 | Merck & Co., Inc. | Cyclic FR-900520 microbial biotransformation agent |
US5283183A (en) * | 1992-09-28 | 1994-02-01 | Merck & Co., Inc. | Cyclic FR-900520 microbial biotransformation agent |
US5290689A (en) * | 1992-09-28 | 1994-03-01 | Merck & Co., Inc. | New cyclic FR-900520 microbial biotransformation agent |
-
1952
- 1952-03-17 GB GB6828/52A patent/GB715362A/en not_active Expired
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2789983A (en) * | 1954-08-03 | 1957-04-23 | Commercial Solvents Corp | Recovery of cycloserine |
US2885433A (en) * | 1954-08-19 | 1959-05-05 | Lab Francais Chimiotherapie | O-carbamyl-d-serine |
US2772281A (en) * | 1954-12-23 | 1956-11-27 | Merck & Co Inc | Synthesis of 4-amino-3-isoxazolidone and its derivatives |
US2840565A (en) * | 1954-12-23 | 1958-06-24 | Merck & Co Inc | Optical isomers of 4-amino-3-isoxazolidone |
US2845432A (en) * | 1954-12-23 | 1958-07-29 | Merck & Co Inc | Benzamido and acetamido 4-amino-3-isoxazolidones and alkylated derivatives |
US2845433A (en) * | 1955-02-04 | 1958-07-29 | Merck & Co Inc | Extraction of 4-amino-3-isoxazolidone |
US3010642A (en) * | 1955-02-16 | 1961-11-28 | Rheinische Maschinen Und App G | Radial flow supersonic compressor |
US2815348A (en) * | 1955-03-21 | 1957-12-03 | Commercial Solvents Corp | Process of producing acetyl cycloserine |
US2794022A (en) * | 1955-03-25 | 1957-05-28 | Commerical Solvents Corp | Production of cycloserine |
US5221625A (en) * | 1992-01-10 | 1993-06-22 | Merck & Co., Inc. | Cyclcic FR-900520 microbial biotransformation agent |
US5268281A (en) * | 1992-09-28 | 1993-12-07 | Merck & Co., Inc. | Cyclic FR-900520 microbial biotransformation agent |
US5268282A (en) * | 1992-09-28 | 1993-12-07 | Merck & Co., Inc. | Cyclic FR-900520 microbial biotransformation agent |
US5283183A (en) * | 1992-09-28 | 1994-02-01 | Merck & Co., Inc. | Cyclic FR-900520 microbial biotransformation agent |
US5290689A (en) * | 1992-09-28 | 1994-03-01 | Merck & Co., Inc. | New cyclic FR-900520 microbial biotransformation agent |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB715362A (en) | Improvements in or relating to antimicrobial agent | |
GB1355734A (en) | Process for producing antibiotic material | |
GB1038242A (en) | Bleomycin and processes for preparation thereof | |
Matsuoka et al. | Unamycin, an antifungal substance produced by Streptomyces fungicidicus | |
GB1163270A (en) | A new Antibiotic Enduracidin and a process for the production thereof | |
GB817385A (en) | Process for the production of an antibiotic designated kanamycin | |
GB729208A (en) | Improvements in or relating to a new antibiotic p.a. 95 and the preparation thereof | |
GB764198A (en) | The antibiotic vengicide and processes for the preparation of the antibiotics oxytetracycline and vengicide | |
GB862685A (en) | New antibiotic designated pa 155a | |
US2936307A (en) | Process of antibiotic extraction | |
GB829327A (en) | Novel antibiotic designated marcomycin and process of making same | |
GB793797A (en) | Improvements in or relating to antibiotics | |
GB708159A (en) | A new antibiotic (erythromycin) and a process for preparing same | |
GB795289A (en) | An antibiotic vancomycin and its production by fermentation | |
GB684417A (en) | A new antibiotic and a process for the production thereof | |
GB768364A (en) | A new antibiotic anisomycin | |
GB708686A (en) | Antibiotic d-13 and its production | |
GB872734A (en) | The fermentative production of the antibiotics distamycine and distacyne | |
GB912339A (en) | Process for the manufacture of the antibiotic pilosomycin, its components and salts thereof | |
GB779570A (en) | A new antibiotic streptolydigin | |
GB787895A (en) | Production of the antibiotic tetracycline by fermentation | |
GB906212A (en) | The antibiotic valacidin and its salts and methods for producing same | |
SE305844B (en) | ||
GB768971A (en) | Antibiotic d-52, its salts and method of preparation | |
GB757089A (en) | Improvements in or relating to antibiotics |